Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets are a combination of Levocetrizine, an antihistamine, and Montelukast, a leukotriene receptor antagonist. This compound is classified within pharmacological categories used to treat allergic conditions and asthma.<\/p>\n
In the pharmaceutical context, Levocetrizine is primarily utilized for the management of allergic rhinitis and chronic urticaria, while Montelukast is effective in preventing asthma attacks and addressing exercise-induced bronchoconstriction. Both compounds are essential in various therapeutic formulations aimed at improving patients’ quality of life.<\/p>\n
This combination tablet holds regulatory significance as it is often prescribed in complex treatment regimens, necessitating compliance with health authorities’ guidelines to ensure safety and efficacy.<\/p>\n
Pharmint offers unparalleled global sourcing capabilities for Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets. Our products come with comprehensive documentation, including Certificate of Analysis (COA)<\/a> and Material Safety Data Sheet (MSDS), ensuring compliance with international regulatory standards.<\/p>\n We provide bulk availability, allowing for seamless procurement processes, and our efficient export support minimizes lead time<\/a>s, enhancing your supply chain’s reliability when compared to typical vendors.<\/p>\n Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets should be stored in a cool, dry place, away from direct light and moisture. Optimal storage temperature is between 15°C to 30°C. Ensure that the product is kept in airtight packaging to maintain its integrity, especially for bulk or research-grade material.<\/p>\n This product is not classified as a controlled precursor; however, an end-use declaration may be required depending on jurisdiction. Available documents include COA and MSDS to ensure compliance with regulatory standards.<\/p>\n This combination effectively manages allergic reactions and asthma, providing dual action for enhanced patient care.<\/p>\n Store in a cool, dry place, away from direct light. Maintain at 15°C to 30°C in airtight packaging.<\/p>\nStorage & Handling Guidelines for Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets<\/h4>\n
Regulatory, Documentation & Export Information<\/h4>\n
Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets FAQs<\/h2>\n
What are the key benefits of Levocetrizine + Montelukast combination?<\/h4>\n
How should Levocetrizine + Montelukast tablets be stored?<\/h4>\n
What documentation is required for procurement?<\/h4>\n